Cancer Clinical Trial -Alpine Immune Sciences-AIS-B01

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies (NEON-1)

Drug

ALPN-202

Phase

Phase I

Condition

Advanced Solid Tumors, Cutaneous Melanoma

Keywords

PDL1